ARDELYX INC. - COMMON STOCK

Ardelyx Announces Launch of Gut Matters: Discoveries and Innovations, a New Podcast for the IBS-C Patient Community

22 10月 2024 15:05:00 条件 Nasdaq GlobeNewswire

Ardelyx Announces the Derek Forfang Patient Advocate Award to Recognize Advocates for the Chronic Kidney Disease Community

21 10月 2024 15:05:00 条件 Nasdaq GlobeNewswire

Ardelyx to Report Third Quarter 2024 Financial Results on October 31, 2024

17 10月 2024 07:00:00 条件 Nasdaq GlobeNewswire

Ardelyx to Present Additional Data Supporting First-In-Class XPHOZAH® (tenapanor) for Adults with Chronic Kidney Disease on Dialysis at the American Society of Nephrology’s Kidney Week

15 10月 2024 07:00:20 条件 Nasdaq GlobeNewswire

Ardelyx Announces Publication of a Review Article Exploring the Patient Burden and Therapeutic Landscape of IBS-C in the U.S. in Clinical and Experimental Gastroenterology

09 10月 2024 07:05:00 条件 Nasdaq GlobeNewswire

Ardelyx to Participate at the 2024 Cantor Global Healthcare Conference

05 9月 2024 07:00:00 条件 Nasdaq GlobeNewswire

Ardelyx Appoints Experienced Biopharma Executive, Eric Foster, as Chief Commercial Officer

08 8月 2024 07:00:00 条件 Nasdaq GlobeNewswire

Ardelyx Reports Second Quarter 2024 Financial Results and Provides Business Update

01 8月 2024 15:01:02 条件 Nasdaq GlobeNewswire

Ardelyx Announces Publication of Two Plain Language Summaries from XPHOZAH® (tenapanor) Clinical Trials in Current Medical Research and Opinion

31 7月 2024 07:02:00 条件 Nasdaq GlobeNewswire

Ardelyx to Report Second Quarter 2024 Financial Results on August 1, 2024

18 7月 2024 07:00:00 条件 Nasdaq GlobeNewswire

Ardelyx, AAKP and NMQF File Lawsuit to Protect Dialysis Patient Choice and Timely Access to Clinically Meaningful Medicines

17 7月 2024 16:10:43 条件 Nasdaq GlobeNewswire

To Preserve Patient Access to XPHOZAH®, Ardelyx Chooses Not to File for TDAPA

02 7月 2024 06:00:00 条件 Nasdaq GlobeNewswire

Ardelyx Presents Additional Data Detailing Educational Needs Related to IBS-C Management Across Healthcare Disciplines

28 6月 2024 07:17:59 条件 Nasdaq GlobeNewswire

Ardelyx, Inc. Reports Employment Inducement Grants

30 5月 2024 15:02:00 条件 Nasdaq GlobeNewswire

Ardelyx to Participate at the 2024 Jefferies Global Healthcare Conference

22 5月 2024 07:02:00 条件 Nasdaq GlobeNewswire

Ardelyx Presents Additional Data at the 2024 Digestive Disease Week Conference on IBSRELA® (tenapanor), a First-In-Class Treatment for IBS-C in Adults

21 5月 2024 07:02:21 条件 Nasdaq GlobeNewswire

Ardelyx Presents Additional Data at the NKF 2024 Spring Clinical Meetings on XPHOZAH® (tenapanor)

16 5月 2024 07:01:41 条件 Nasdaq GlobeNewswire

Ardelyx, Inc. Reports Employment Inducement Grants

14 5月 2024 15:02:00 条件 Nasdaq GlobeNewswire

Ardelyx to Present Additional Data Supporting First-In-Class IBSRELA® (tenapanor) for Adults with Irritable Bowel Syndrome with Constipation at the 2024 Digestive Disease Week Conference

07 5月 2024 07:01:45 条件 Nasdaq GlobeNewswire

Ardelyx Reports First Quarter 2024 Financial Results and Provides Business Update

02 5月 2024 15:02:28 条件 Nasdaq GlobeNewswire